Home | Business News | CBJ Newsmakers | Resverlogix Cognition Substudy of the BETonMACE Phase 3 Cardiovascular Trial Presented at the International Conference on Alzheimer’s & Parkinson’s Diseases Resverlogix Cognition Substudy of the BETonMACE Phase 3 Cardiovascular Trial Presented at the International Conference on Alzheimer’s & Parkinson’s Diseases RecommendedCanada’s just-for-moms small business grant program returns for its fifth yearCority Bolsters Leadership With Appointment of Ted Kail as the New Chief Product OfficerH2O Innovation Awarded New O&M Contract and Renews Existing Contracts, Amounting to $7.1 M
